News & Events
February 18, 2019
First Cannabis Patent to Survive IPR Challenge In Part By: Katie Rubino On January 3rd, 2019 the Patent Trial and Appeal Board (PTAB) issued a final […]
February 5, 2019
CAFC Rules USPTO Exceeded Its Authority Adjusting Patent Term By: Katie Rubino Recently on January 27th, 2019 the U.S. Court of Appeals for the Federal Circuit […]
January 27, 2019
Buyer Beware: Secret Sales May Result in Subsequent Patent Invalidity By: Katie Rubino Recently on January 22, 2019, the Supreme Court affirmed the Federal Circuit’s […]
January 18, 2019
Final Decision Reached in Initial Insulin IPR Proceeding By: Katie Rubino On December 12th, 2018 the U.S. Patent and Trademark Appeal Board (PTAB) […]
January 11, 2019
How to Allocate Resources to Intellectual Property as a Start-Up By: Katie Rubino When a venture is first getting off the ground, there […]
December 10, 2018
A review of new patent strategies developing around protein kinase inhibitors by patent attorney Katie Rubino.
November 29, 2018
Five Takeaways from seminar on changing cannabis laws in New England by Judge Mary Celeste.
November 18, 2018
Legal Review: The United States-Mexico-Canada Agreement compared with NAFTA as it relates to IP, with a special focus on how it could affect chemical and biological pharmaceutical products.
November 7, 2018
Are auditability and transparency exclusive to open-source software? Our expert panel discusses blockchain patents and the “Silcone Valley mindset" at our recent MIT Enterprise Forum event.
November 5, 2018
Court Case Review: University of California v. Broad Institute, Inc. #2017-1907 by Patent Attorney Katie Rubino. Case involves CRISPR-Cas9 patents held by Harvard and MIT.